Clinical Trial Update: Vortioxetine for Treatment of Depressive Mood and Alcohol Use [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on vortioxetine for depressive mood in individuals with major depressive disorder and alcoholism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: Depressive Disorder, Major, Alcoholism | Phase 2 | Status: UNKNOWN